Serum anti-NMDA-receptor antibodies and cognitive function after ischemic stroke (PROSCIS-B)

OBJECTIVE: We aimed to investigate whether serum anti-N-methyl-D-aspartate-receptor GluN1 (previously NR1) antibody (NMDAR1-abs) seropositivity impacts cognitive function (CF) in the long term following ischemic stroke. METHODS: Data were used from the PROSpective Cohort with Incident Stroke-Berlin....

Descripción completa

Detalles Bibliográficos
Autores principales: Sperber, Pia S., Gebert, Pimrapat, Broersen, Leonie H. A., Huo, Shufan, Piper, Sophie K., Teegen, Bianca, Heuschmann, Peter U., Prüss, Harald, Endres, Matthias, Liman, Thomas G., Siegerink, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468072/
https://www.ncbi.nlm.nih.gov/pubmed/35718820
http://dx.doi.org/10.1007/s00415-022-11203-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468072/
https://www.ncbi.nlm.nih.gov/pubmed/35718820
http://dx.doi.org/10.1007/s00415-022-11203-x

Ejemplares similares